T/CACM 1224-2019 Active Group standards

T/CACM 1224-2019 Chinese Internal Medicine Guideline for the Clinical Management of Ischemic Heart Disease

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1224-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline proposes recommendations for the diagnosis, differential diagnosis, treatment, prevention, and care of ischemic cardiomyopathy (chronic stable phase). This guideline is applicable to the diagnosis and treatment of ischemic cardiomyopathy in the above-mentioned groups. This guideline is for reference by doctors in cardiology departments and departments of integrated traditional and Western medicine